Administering antisense oligonucleotides complementary to human apolipoprotein B

Details for Australian Patent Application No. 2008230886 (hide)

Owner Genzyme Corporation

Inventors Wedel, Mark K.; Yu, Zhengrong; Tribble, Diane; Geary, Richard S.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008230886

PCT Pub. Number WO2008/118883

Priority 60/896,914 24.03.07 US

Filing date 24 March 2008

Wipo publication date 2 October 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/118883 Priority application(s): WO2008/118883

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008230888-System and method for increasing demand for perishable goods at a point-of sale location utilizing location-based communication

2008230885-Method and apparatus for determining broadcast messages in wireless signals